MEXICO CITY — The best way to manage suprachoroidal hemorrhage is to prevent it, according to José Dalma, MD, in practice here. “The mainstay of treatment of this condition is still its prevention,” ...
ALPHARETTA, Ga., June 12, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
Patients with a history of intraocular surgery often report eye-related symptoms after surgery associated with coughing, straining, vomiting and other Valsalva-related events. In the early ...
ALPHARETTA, Ga., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
Ophthalmology company Clearside Biomedical just announced a $20 million Series C financing round to develop its proprietary formulation of triamcinolone acetonide that's delivered into the eye's ...
ALPHARETTA, Ga., March 20, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to ...
ALPHARETTA, Ga., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
- Proven In-Office, Repeatable, Non-Surgical Procedure for the Targeted Delivery of a Wide Variety of Therapies for Serious Retinal Diseases - - CLS-AX Phase 3-Ready Asset with Global Investigator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback